This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ben-Ezra, J. M. Articles by Krystal, G. Search for Related Content PubMed PubMed Citation Articles by Ben-Ezra, J. M. Articles by Krystal, G.

American Journal of Pathology, Vol 145, 1036-1040, Copyright © 1994 by American Society for Investigative Pathology

REGULAR ARTICLES

Small cell carcinomas of the lung express the Bcl-2 protein

JM Ben-Ezra, MJ Kornstein, MM Grimes and G Krystal
Department of Pathology, Virginia Commonwealth, University/Medical College of Virginia 23298-0662.

In our laboratory, we observed that a case of small cell carcinoma of the lung (SCLC) stained with a monoclonal antibody (Dako Corp., Bcl-2- 124) against the Bcl-2 protein. To determine how common this reaction was, and whether it was specific for SCLC, we stained formalin-fixed, paraffin-embedded tissues from 23 cases of SCLC and 20 cases of squamous cell carcinoma of the lung for Bcl-2. Fifteen of the 23 SCLC cases stained positively for the Bcl-2 oncogene protein. In contrast, weak staining was observed in only three of the squamous cell carcinomas (chi 2-test; P = 0.001). In addition, four small cell carcinoma cell lines (H69, H146, H209, and WB) were tested by immunohistochemistry and flow cytometry for expression of this protein; all four were positive. In these and three other (H128, H432, and H510) SCLC lines, Northern blots of polyadenylated RNA revealed expression of the 6-kb Bcl-2 mRNA. Moreover, Western blots of extracts from these cell lines revealed the characteristic 26-kd band for Bcl-2 protein. In a single cell line, H82, which has previously been characterized as a variant SCLC, we failed to detect expression of the Bcl-2-specific mRNA and protein. We therefore conclude that most cases of SCLC of the lung express the Bcl-2 oncoprotein, which could play a role in the pathogenesis of this disease.

This article has been cited by other articles:

				A. M. Davies, P. N. Lara Jr., P. C. Mack, and D. R. Gandara Incorporating Bortezomib into the Treatment of Lung Cancer Clin. Cancer Res., August 1, 2007; 13(15): 4647s - 4651s. [Abstract] [Full Text] [PDF]

				N. Azad, V. Vallyathan, L. Wang, V. Tantishaiyakul, C. Stehlik, S. S. Leonard, and Y. Rojanasakul S-Nitrosylation of Bcl-2 Inhibits Its Ubiquitin-Proteasomal Degradation: A NOVEL ANTIAPOPTOTIC MECHANISM THAT SUPPRESSES APOPTOSIS J. Biol. Chem., November 10, 2006; 281(45): 34124 - 34134. [Abstract] [Full Text] [PDF]

				A. R. Shoemaker, A. Oleksijew, J. Bauch, B. A. Belli, T. Borre, M. Bruncko, T. Deckwirth, D. J. Frost, K. Jarvis, M. K. Joseph, et al. A Small-Molecule Inhibitor of Bcl-XL Potentiates the Activity of Cytotoxic Drugs In vitro and In vivo. Cancer Res., September 1, 2006; 66(17): 8731 - 8739. [Abstract] [Full Text] [PDF]

				P. Chanvorachote, U. Nimmannit, C. Stehlik, L. Wang, B.-H. Jiang, B. Ongpipatanakul, and Y. Rojanasakul Nitric Oxide Regulates Cell Sensitivity to Cisplatin-Induced Apoptosis through S-Nitrosylation and Inhibition of Bcl-2 Ubiquitination. Cancer Res., June 15, 2006; 66(12): 6353 - 6360. [Abstract] [Full Text] [PDF]

				R. S. Herbst and S. R. Frankel Oblimersen Sodium (Genasense bcl-2 Antisense Oligonucleotide): A Rational Therapeutic to Enhance Apoptosis in Therapy of Lung Cancer Clin. Cancer Res., June 15, 2004; 10(12): 4245S - 4248S. [Abstract] [Full Text] [PDF]

				A. Gradilone, P. Gazzaniga, D. Ribuffo, S. Scarpa, E. Cigna, F. Vasaturo, U. Bottoni, D. Innocenzi, S. Calvieri, N. Scuderi, et al. Survivin, bcl-2, bax, and bcl-X Gene Expression in Sentinel Lymph Nodes From Melanoma Patients J. Clin. Oncol., January 15, 2003; 21(2): 306 - 312. [Abstract] [Full Text] [PDF]

				C. Bonzon and H. Fan Moloney Murine Leukemia Virus-Induced Tumors Show Altered Levels of Proapoptotic and Antiapoptotic Proteins J. Virol., September 1, 2000; 74(17): 8151 - 8158. [Abstract] [Full Text]

				Y. Ohmura, M. Aoe, A. Andou, and N. Shimizu Telomerase Activity and Bcl-2 Expression in Non-Small Cell Lung Cancer Clin. Cancer Res., August 1, 2000; 6(8): 2980 - 2987. [Abstract] [Full Text]

				S. E. Blutt, T. J. McDonnell, T. C. Polek, and N. L. Weigel Calcitriol-Induced Apoptosis in LNCaP Cells Is Blocked By Overexpression of Bcl-2 Endocrinology, January 1, 2000; 141(1): 10 - 17. [Abstract] [Full Text] [PDF]

				A.-M. C. Dingemans, M. A. Witlox, R. A. L. M. Stallaert, P. van der Valk, P. E. Postmus, and G. Giaccone Expression of DNA Topoisomerase II{{alpha}} and Topoisomerase II{beta} Genes Predicts Survival and Response to Chemotherapy in Patients with Small Cell Lung Cancer Clin. Cancer Res., August 1, 1999; 5(8): 2048 - 2058. [Abstract] [Full Text] [PDF]

				S. Eissa and L. S. Seada Quantitation of bcl-2 protein in bladder cancer tissue by enzyme immunoassay: comparison with Western blot and immunohistochemistry Clin. Chem., July 1, 1998; 44(7): 1423 - 1429. [Abstract] [Full Text] [PDF]

				P. J. Bernier and A. Parent Bcl-2 Protein as a Marker of Neuronal Immaturity in Postnatal Primate Brain J. Neurosci., April 1, 1998; 18(7): 2486 - 2497. [Abstract] [Full Text] [PDF]